29 July 2015 - Immunogenicity Coaching Event in October 2015
Immunogenicity, Part III: Monitoring and Assessment of Clinical Immunogenicity (12 October 2015)
The 3rd event of this series focuses on the clinical parameters that need to be considered in designing clinical studies to receive a database for the interpretation of immunogenicity data. Discussion into product-specific such as biosimilars will be addressed on how clinically significant signals can be complemented by post-approval monitoring.
Find out more about the event here.